Evidence map›Paper›PMID 25880289›Full record

ArticleAnatolian journal of cardiology2015

The protective effect of single dose tadalafil in contrast-induced nephropathy: an experimental study.

Kerem Özbek, Köksal Ceyhan, Fatih Koç, Erkan Söğüt, Fatih Altunkaş, Metin Karayakalı, Ataç Çelik, Hasan Kadı, R Doğan Köseoğlu, Orhan Önalan

Open access · bronzeAbstract read
In one paragraph

Article in Anatolian journal of cardiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Kerem ÖzbekDepartment of Cardiology, Faculty of Medicine, Gaziosmanpaşa University; Tokat-Turkey. keremozbek@doctor.com.
Köksal Ceyhan
Fatih Koç
Erkan Söğüt
Fatih Altunkaş
Metin Karayakalı
Ataç Çelik
Hasan Kadı
R Doğan Köseoğlu
Orhan Önalan
Tokat Gaziosmanpaşa Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveContrast-induced nephropathy (CIN) is one of the most common causes of acute renal failure in hospitalized patients. The direct toxic effect of contrast media; ischemic damage caused by reactive oxygen species; increased perivascular hydrostatic pressure; high viscosity and changes in the activity of vasoactive substances play important roles in the pathogenesis. Tadalafil inhibits the phosphodiesterase enzyme which destroys nitric oxide. Nitric oxide causes renal vasodilatation, increases renal medullar blood flow and mediates the removal of free oxygen radicals. Drugs that increase levels of nitric oxide are expected to reduce the development of contrast nephropathy due to contrast media. We aimed to test the hypothesis that tadalafil reduces the development of contrast nephropathy due to contrast toxicity.

methodsA total of 24 female Wistar albino rats, three groups of eight, were included in the study. After 48 hours of dehydration, contrast media (meglumine diatrozoate, 6 mL/kg) was administered to the first group, and contrast media with tadalafil (10 mg/kg) was administered to the second group. The third group served as the control group. Blood and tissue samples were taken 48 hours after this procedure.

resultsSerum cystatin C, serum creatinine and blood urea nitrogen (BUN) values were significantly lower in the contrast with tadalafil group compared to the group given only contrast. Serum and tissue malondialdehyde (MDA) levels were significantly lower in the contrast with tadalafil group than in the contrast only group.

conclusionThese results demonstrate the protective effect of tadalafil in the prevention of CIN in rats.

Indexed as

Administration, OralAnimalsContrast MediaDose-Response Relationship, DrugFemaleMalondialdehydePhosphodiesterase 5 InhibitorsRatsRats, WistarRenal InsufficiencyTadalafilContrast MediaMalondialdehydePhosphodiesterase 5 InhibitorsTadalafil

Identifiers

PMID25880289
PMCPMC5336839
OpenAlexW2313129929

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.